Scancell Holdings plc (SCLP.L)
Develops immunotherapy treatments that train the immune system to fight cancer.
10.00+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-2.4%
The outlook
Scancell Holdings trades near its 52-week low, currently below both its 50- and 200-day moving averages. The two analysts covering the stock rate it "Strong Buy" with an average price target roughly 155% above today's level. The stock's position in its recent trend suggests weakness, though analyst sentiment remains notably bullish.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +155% vs current price
Analyst price target
~12-month · 2 analysts25.50average target+155.0% vs now
Now 10.00
Low 19.00High 32.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$103.8M
52-wk high
29.50
52-wk low
7.86
50-day avg
18.00
200-day avg
13.62
Trailing P/E
—